Two Sigma Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-51,419
| Closed | -$4.94M | – | 1261 |
|
|
2025
Q4 | $4.94M | Buy |
51,419
+2,487
| +5% | +$242K | 0.01% | 825 |
|
|
2025
Q3 | $4.66M | Sell |
48,932
-207,588
| -81% | -$19.1M | 0.01% | 771 |
|
|
2025
Q2 | $22.4M | Sell |
256,520
-539,700
| -68% | -$45.8M | 0.05% | 318 |
|
|
2025
Q1 | $71.5M | Buy |
796,220
+555,200
| +230% | +$49.7M | 0.16% | 134 |
|
|
2024
Q4 | $19.3M | Sell |
241,020
-92,200
| -28% | -$7.98M | 0.04% | 329 |
|
|
2024
Q3 | $30M | Buy |
333,220
+189,088
| +131% | +$15.9M | 0.07% | 240 |
|
|
2024
Q2 | $11.3M | Buy |
144,132
+103,732
| +257% | +$8.5M | 0.03% | 501 |
|
|
2024
Q1 | $3.52M | Sell |
40,400
-231,332
| -85% | -$19.7M | 0.01% | 939 |
|
|
2023
Q4 | $22.4M | Sell |
271,732
-2,371,588
| -90% | -$181M | 0.05% | 305 |
|
|
2023
Q3 | $207M | Sell |
2,643,320
-416,300
| -14% | -$34.8M | 0.53% | 42 |
|
|
2023
Q2 | $270M | Sell |
3,059,620
-1,385,300
| -31% | -$119M | 0.69% | 27 |
|
|
2023
Q1 | $358M | Sell |
4,444,920
-911,400
| -17% | -$74.3M | 0.92% | 17 |
|
|
2022
Q4 | $416M | Buy |
5,356,320
+754,400
| +16% | +$61.1M | 1.16% | 10 |
|
|
2022
Q3 | $372M | Buy |
4,601,920
+1,439,900
| +46% | +$129M | 1.08% | 14 |
|
|
2022
Q2 | $284M | Buy |
3,162,020
+148,200
| +5% | +$15M | 0.81% | 22 |
|
|
2022
Q1 | $334M | Sell |
3,013,820
-1,157,800
| -28% | -$122M | 0.89% | 17 |
|
|
2021
Q4 | $432M | Buy |
4,171,620
+1,192,100
| +40% | +$138M | 1.08% | 8 |
|
|
2021
Q3 | $373M | Sell |
2,979,520
-306,300
| -9% | -$39.6M | 0.97% | 19 |
|
|
2021
Q2 | $408M | Buy |
3,285,820
+1,694,400
| +106% | +$213M | 1.08% | 9 |
|
|
2021
Q1 | $188M | Buy |
1,591,420
+954,500
| +150% | +$112M | 0.52% | 36 |
|
|
2020
Q4 | $74.6M | Sell |
636,920
-1,267,900
| -67% | -$140M | 0.2% | 109 |
|
|
2020
Q3 | $198M | Buy |
1,904,820
+329,900
| +21% | +$33.1M | 0.57% | 44 |
|
|
2020
Q2 | $144M | Buy |
1,574,920
+1,255,988
| +394% | +$120M | 0.42% | 42 |
|
|
2020
Q1 | $28.8M | Buy |
318,932
+76,735
| +32% | +$8.16M | 0.11% | 215 |
|
|
2019
Q4 | $27.5M | Buy |
242,197
+55,321
| +30% | +$6.07M | 0.06% | 313 |
|
|
2019
Q3 | $20.3M | Buy |
186,876
+181,440
| +3,338% | +$18.9M | 0.05% | 368 |
|
|
2019
Q2 | $529K | Sell |
5,436
-115,766
| -96% | -$10.6M | ﹤0.01% | 1787 |
|
|
2019
Q1 | $11M | Sell |
121,202
-336,700
| -74% | -$30.1M | 0.03% | 564 |
|
|
2018
Q4 | $41.7M | Buy |
457,902
+408,066
| +819% | +$38.1M | 0.11% | 223 |
|
|
2018
Q3 | $4.9M | Buy |
49,836
+31,900
| +178% | +$2.95M | 0.01% | 828 |
|
|
2018
Q2 | $1.54M | Sell |
17,936
-324,600
| -95% | -$27.1M | ﹤0.01% | 1423 |
|
|
2018
Q1 | $27.5M | Sell |
342,536
-712,566
| -68% | -$58.8M | 0.07% | 326 |
|
|
2017
Q4 | $85.2M | Sell |
1,055,102
-135,176
| -11% | -$10.8M | 0.23% | 114 |
|
|
2017
Q3 | $92.6M | Buy |
1,190,278
+655,654
| +123% | +$54.4M | 0.26% | 101 |
|
|
2017
Q2 | $47.4M | Sell |
534,624
-1,139,678
| -68% | -$96.1M | 0.16% | 163 |
|
|
2017
Q1 | $135M | Sell |
1,674,302
-1,377,856
| -45% | -$108M | 0.44% | 39 |
|
|
2016
Q4 | $217M | Buy |
3,052,158
+2,988,254
| +4,676% | +$235M | 0.83% | 8 |
|
|
2016
Q3 | $5.52M | Buy |
+63,904
| New | +$5.57M | 0.02% | 613 |
|
|
2015
Q1 | – | Sell |
-128,970
| Closed | -$9.31M | – | 2192 |
|
|
2014
Q4 | $9.31M | Buy |
128,970
+105,500
| +450% | +$7.33M | 0.07% | 323 |
|
|
2014
Q3 | $1.45M | Sell |
23,470
-61,900
| -73% | -$3.94M | 0.01% | 944 |
|
|
2014
Q2 | $5.44M | Buy |
85,370
+75,270
| +745% | +$4.57M | 0.04% | 447 |
|
|
2014
Q1 | $621K | Sell |
10,100
-14,240
| -59% | -$829K | 0.01% | 1435 |
|
|
2013
Q4 | $1.4M | Sell |
24,340
-236,400
| -91% | -$13.4M | 0.01% | 951 |
|
|
2013
Q3 | $13.9M | Buy |
260,740
+236,519
| +977% | +$12.7M | 0.17% | 135 |
|
|
2013
Q2 | $1.25M | Buy |
+24,221
| New | +$1.2M | 0.02% | 750 |
|
Other funds holding MDT
VCM
VPM
Two Sigma Advisers's MDT Position: Q1 2026 in Review
Two Sigma Advisers sold out of Medtronic (MDT) in Q1 2026, closing a stake of 51,419 shares — an estimated $4.94M sold.
Two Sigma Advisers first reported a position in MDT in Q2 2013 and held it in 45 quarters. The position peaked at $432M in Q4 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Two Sigma Advisers reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 51,419 Medtronic shares in Q1 2026, an estimated $4.94M.
- Two Sigma Advisers first reported a position in Medtronic in Q2 2013 and held it in 45 quarters.
- Two Sigma Advisers's Medtronic position peaked at $432M in Q4 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.